Poliovirus vaccine live oral trivalent - Panacea Biotec

Drug Profile

Poliovirus vaccine live oral trivalent - Panacea Biotec

Alternative Names: OPV trivalent - Panacea Biotec; Primopol; Trivalent oral poliovirus vaccine - Panacea Biotec

Latest Information Update: 20 Feb 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Panacea Biotec
  • Class Viral vaccines; Viruses
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Poliomyelitis

Most Recent Events

  • 01 Dec 2013 Launched for Poliomyelitis (prevention) in India (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top